Denali Therapeutics Inc (DNLI)
CapEx to Revenue
22.34%
Quarterly · Period ending:
DNLI CapEx to Revenue
Latest reported22.34%period ending
Latest reported22.34%period ending
DNLI Quarterly CapEx/Revenue (0.00% → 22.34%)
Latest values, visible window
High-resolution chart · PNG
DNLI capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 22.3363% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 163.2202% | |
| 1.989% | |
| 7.9281% | |
| 47.1555% | |
| 169.9916% | |
| 5.5126% | |
| 9.5892% | |
| 24.3967% | |
| 35.4778% | |
| 3.3654% | |
| 35.3401% | |
| 0.3772% | |
| 7.5162% | |
| 5.3874% | |
| 24.3896% | |
| 59.3536% | |
| 20.9277% | |
| 244.7224% | |
| 48.2283% | |
| 1.1434% | |
| 70.8787% | |
| 34.7087% | |
| 83.7754% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |